Parallel Screening, European Pharmaceutical Contractor

Drug Manufacturers, Technology

Parallel Screening, European Pharmaceutical Contractor

By Patheon

By Kwok Chow, PhD, and Anil Kane, PhD

Improving the bioavailability of poorly soluble new chemical entities is a leading challenge in drug development.

Parallel screening is a cost-effective concept for selecting a suitable drug delivery system to enhance the chance of achieving the bioavailability target in the clinic.

Download to find out more.

Enter your details below to view the free white paper

By downloading this whitepaper, you acknowledge that GlobalData may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our for more information about our services, how GlobalData may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

网曝门